Increased urinary orosomucoid excretion predicts preeclampsia in pregnant women with pregestational type 1 diabetes

AimsWe evaluated the urinary orosomucoid excretion (UOE) as a biomarker of preeclampsia and preterm delivery in pregnant women with type 1 diabetes.MethodsSingleton pregnant women with pregestational type 1 diabetes were included provided one urine sample had been collected before 17 gestational weeks. Serum and urinary orosomucoid were analysed by immunoturbidimetry. Primary outcome measurements were development of preeclampsia (blood pressure > 140/90 mmHg and proteinuria) and preterm delivery before 37 weeks.ResultsIn total 173 women were included. The UOE increased during pregnancy. Preeclampsia developed in 20 women and 65 women delivered preterm. Using logistic regression analysis we found that UOE > 1.37 mg/l (OR: 6.85 (95% CI: 1.97–23.88; p < 0.003)), nulliparity (3.88 (1.10–13.72); p < 0.04), systolic blood pressure > 120 mmHg (4.12 (1.35–12.59); p < 0.02) and duration of diabetes > 20 years (3.69 (1.18–11.52); p < 0.03) independently predicted the development of preeclampsia. Independent predictors of preterm delivery were duration of diabetes and HbA1c > 7%. The remaining covariates included in the regression models were BMI, serum creatinine, smoking and microalbuminuria.ConclusionsIncreased UOE early in pregnancy predicted preeclampsia in women with pregestational type 1 diabetes independently of albuminuria and other known risk factors. No association to preterm delivery was found.